Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed2
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT00026091Phase 2Completed
Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
Recurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IV Ovarian Epithelial Cancer+1 more
Principalinvestigator
NCT01155258Phase 1Completed
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
Principalinvestigator
NCT01695057Not ApplicableWithdrawn
Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer
Stage II Breast CancerStage IIIA Breast CancerTriple-negative Breast Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Breast CancerRecurrent Breast CancerStage IV Prostate Cancer+3 more
Similarity Score3%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Breast CancerStage II Breast CancerStage IIIA Breast Cancer+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Recurrent Breast CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
Similarity Score2%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Stage III Renal Cell CancerStage IV Prostate CancerStage IV Renal Cell Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Breast CancerRecurrent Prostate CancerTriple Negative Breast Neoplasms
Similarity Score2%

Jose CA Carvalho, MD

MOUNT SINAI HOSPITAL

Related
27 trials

Shared therapeutic areas:

NauseaVomiting
Similarity Score1%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score1%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score1%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score1%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT01649258Phase 1PrincipalInvestigator

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

Breast CancerNauseaVomiting
Terminated
NCT00026091Phase 2PrincipalInvestigator

Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Recurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IV Ovarian Epithelial Cancer+1 more
Completed
NCT01155258Phase 1PrincipalInvestigator

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
Completed
NCT01695057Not ApplicablePrincipalInvestigator

Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer

Stage II Breast CancerStage IIIA Breast CancerTriple-negative Breast Cancer
Withdrawn

All 4 trials loaded